FDA approval for iron deficiency drug boosts Shield Therapeutics
Speciality pharmaceutical company Shield Therapeutics (STX:AIM), announced that the US Food and Drug Administration (FDA) had approved its main product aimed at treating iron deficiency in adults with a broader than expected label,...
26 July 2019
